Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
Vroege FDG PET/CT-scan identificeert darmkankerpatiënt die geen baat heeft bij anti-EGFR-therapie
sep 2024 | Maag-darm-leveroncologie